Digital Health Startups A FirstWord ExpertViews Dossier Report
|
|
- Wilfred Jefferson
- 5 years ago
- Views:
Transcription
1 AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report
2 Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping or storage in information retrieval systems without the express permission of the publisher. This report contains information from numerous sources that Doctor s Guide Publishing Limited believes to be reliable but for which accuracy cannot be guaranteed. Doctor s Guide Publishing Limited does not accept responsibility for any loss incurred by any person who acts or who fails to act as a result of information published in this document. Any views and opinions expressed by third parties and reproduced in this document are not necessarily the views and opinions of Doctor s Guide Publishing Limited. Any views and opinions expressed by individuals and reproduced in this document are not necessarily the views and opinions of their employers. Cover image: everythingpossible AdobeStock
3 Contents All Contents Copyright 2016 i Executive summary... 1 Research objectives and methodology...4 Expert Contributors...6 Pharma Company Expert Contributors...8 : Company profiles and analysis...10 In-depth profiles...10 Accel Diagnostics...10 Kit Check...14 LuminaCare Solutions...18 Omada Health...22 Proteus Digital Health...26 Zocdoc...30 Summary profiles...33 Dexcom...33 Fit4D...35 RxREVU Tute Genomics...39 Trends underlying the growth of digital health technology The growth of smartphones Big Data and AI Digital engagement Connected devices... 41
4 ii Funding of digital health ventures...42 Major themes...42 Investment landscape...43 Exit tally...43 Pharma company involvement in digital health...44 Most pharmaceutical companies are involved in harnessing digital health technology...45 Pharma s level of commitment to digital health technology viewed as insufficient There are many areas in which pharma can gain from technology developed by digital health companies Pharma patient engagement could be disrupted if pharma fails to establish a foothold in certain digital health technologies...48 Opportunities for pharma to act as venture capital investor and incubator in the digital health sector...48 Industry should act as an accelerator for transformation of healthcare through collaboration with digital health companies...50 Digital health innovation provides pharma with opportunities to develop a competitive advantage across the value chain Evangelists of digital health technology do not yet command significant influence Clinical trials and beyond the pill services are high growth areas...52 Barriers holding back the progress of digital innovation...54 The role of technology giants venture capital arms...56 Future trends that will propel the further adoption of digital health technology...59
5 4 Research objectives and methodology This FirstWord Dossier report examines digital health innovation through the lens of startup companies that are driving expansion of the sector. The report profiles startup ventures that are reshaping healthcare and affecting conventional pharmaceutical company business models. It looks at the technology and the potential it has to drive significant improvements across the healthcare spectrum. Key research objectives were as follows: Uncover insights that help pharma companies understand the technology and trends Identify areas of opportunity and threat to drug manufacturers Provide inputs to help pharma companies formulate plans in response to changes in the market. Meeting these objectives has been accomplished by providing information, analysis and insights in the following areas: Profiles of key digital health startups Current and future business models of digital health startups Barriers that may hinder the development and use of digital health technology Pharma company involvement in digital health Current and future trends driving progress in digital health technology. The research methodology comprised three main steps. 1. Detailed secondary research into digital health startup companies and investment in the digital health market 2. In-depth interviews with executives from digital health startup companies (n=6) and executives who have experience in and responsibility for the advancement of digital health at major pharma companies (n=4) 3. Collation and analysis of the information gleaned from the primary and secondary research.
6 5 Key questions asked of the executives from digital health startups included: 1. To what extent will the technology developed by your company transform the delivery of healthcare? 2. Who will be the main beneficiaries of this transformation? 3. How will your business model evolve over the next five years? 4. What are the key milestones your startup needs to pass over the next five years? 5. To what extent does the success of your startup depend on collaboration between key stakeholders such as pharma, payers, physicians, patients, regulators and others? 6. Which other digital health startups do you admire and why? 7. What role should pharma s venture capital arms be playing in funding startups and digital innovation generally? 8. What does pharma have to gain from your startup s technology? 9. What does pharma stand to lose if your technology establishes a foothold in the prevention, treatment and management of disease? 10. Which pharma companies do you see playing a big role in digital health in the future and why? The questions were tailored according to each startup s specific area(s) of operation.
7 Expert Contributors All Contents Copyright The following experts from digital health startup companies were interviewed. Adam Brickman: Director, Strategic Communications and Public Policy, Omada Health Markus Christen: Head of Global Development, Proteus Digital Health Alberto Gandini: Chief Executive Officer (CEO), Accel Diagnostics David Howe: CEO, LuminaCare Solutions Oliver Kharraz: CEO, Zocdoc Bret Kinsella: Chief Marketing Officer, Kit Check The report presents 10 profiles of digital health startups. Six of these profiles are based on insights obtained through in-depth interviews with executives from the companies and secondary research into their products, services, business models, key milestones and the impact they could have on the pharma industry. The remaining four profiles have been compiled using publically available information to provide background on the activities and ambitions of the companies. A main criterion used for selecting startup companies to profile was the extent to which they may have an impact on pharmaceutical companies. Another requirement was to cover a range of startups that illustrate the diversity of digital health products and services on offer. Thus the companies selected reflect different categories of size, status of product, complexity of technology and customers served. The digital health startup companies profiled in this report are listed below: Accel Diagnostics is developing point-of-need diagnostic tests Kit Check has developed a medication tracking system used by hospitals LuminaCare Solutions helps hospitals that need to reduce time spent finding the right treatment
8 7 Omada Health aims to help people reduce their risk of developing serious chronic conditions like diabetes Proteus Digital Health has developed technology that monitors drug adherence and other patient behaviour Zocdoc is a patient platform providing services as part of a digital centre of care. Four smaller profiles are provided on other startup ventures. They illustrate how digital health technologies are being used to create novel products and services to facilitate the delivery of healthcare: Dexcom markets a mobile continuous glucose monitoring system Fit4D provides solutions to pharma, payers and providers that promote medical adherence and improve health outcomes in diabetes patients RxREVU offers a technology platform to healthcare providers aimed at improving prescription decisions and health outcomes and lowering drug costs Tute Genomics analyses human genome data for genetic diagnoses.
9 42 Funding of digital health ventures In 2015, venture funding for digital health companies totalled $4.5 billion. From it grew at a compound annual growth rate (CAGR) of 32 percent. In 2015 there were 302 venture funding deals involving 267 companies, inked at an average deal value of $14.8 million. 15 Major themes In 2015, the following six digital health subsectors received 50 percent of all funding: Healthcare consumer engagement Payer administration Wearables and biosensors Telemedicine Care coordination Personal health tools and tracking Noticeable growth was seen in three areas in 2015 over 2014: personal health tools and tracking (223 percent); care coordination (152 percent); and life sciences technologies (49 percent). 15 Extracted from Rock Health, Digital Health Funding: Retrieved from
10 54 Barriers holding back the progress of digital innovation The main barriers to the progress of digital health innovation are lack of reimbursement mechanisms for digital therapeutics and legal and regulatory restrictions. An additional barrier is the desire and need to use the data streams responsibly and to respect privacy. The uncertainty about the future structure of the healthcare industry also holds back the launch of some projects. I think there are a couple [of barriers to digital adoption]. The first one is that there is not an ecosystem set up to reimburse for it yet. If I could project that a digital therapeutic would launch and drive billions of dollars of revenue then I can guarantee that it would catalyse the interest of companies. But we have not seen that setup and we haven t seen any examples. That s certainly an issue. The other big barrier that I would be shocked if every executive would not mention is the legal regulatory framework, because we operate in such a tough environment. Progress in that area will certainly catalyse innovation. Director, Digital Health, large pharma The ever-present uncertainty of the healthcare landscape does not help. Even with the changing legislative and regulatory environment, there are positives and negatives. So that is certainly part of it [barriers to digital health]. Certainly governmental groups exist to protect patients; they exist to help make better decisions and help ensure that a patient participates in a safe and informed manner. But at the same time, it [legislation] can be overly restrictive or it can be difficult for companies to effectively share great information. There is a constant evolution in terms of how much protection is needed and how much information can be shared. Associate Director, Strategic Marketing mid-sized pharmaceutical company Technically, I think a lot of things are in place. Understanding of how to manage, protect and secure data, and getting better at doing so, is evolving. In each case, firstly, we have to prove we can capture the data, and then secondly, we can capture
11 Unique insight into current and future pharma market dynamics through quantitative surveys with physicians, providing essential data in major disease areas and on key industry issues. A personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis, and expert views of importance to your company's success. Critical and unbiased intelligence derived from in-depth interviews with the world s foremost thought leaders on the current and future treatment landscapes in major disease areas. Reports include three quarterly updates to ensure insights remain current. A personalised and comprehensive intelligence service reporting on the latest news and developments for the medical technology and diagnostic industries. Unbiased and concise analysis based on interviews with leading industry experts on important trends and challenging issues affecting the pharma industry today. FirstWord delivers timely, need-to-know intelligence about your products, your competitors and your markets.
Digital Medical Device Innovation: A Prescription for Business and IT Success
10 September 2018 Digital Medical Device Innovation: A Prescription for Business and IT Success A Digital Transformation is reshaping healthcare. New technology, mobility, and advancements in computing
More informationAuthors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry
Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade Digital Patient Engagement Insights for the Pharmaceutical Industry March 2018 2 DIGITAL PATIENT ENGAGEMENT: INSIGHTS FOR THE PHARMACEUTICAL
More informationWritten Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
More informationAdvancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation
Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry
More informationSecurity and Risk Assessment in GDPR: from policy to implementation
Global Data Privacy Security and Risk Assessment in GDPR: from policy to implementation Enisa Workshop Roma - February 8, 2018 Nicola Orlandi Head of Data Privacy Pharma Nicola Orlandi Nicola Orlandi is
More informationHealthTech: What does it mean for compliance?
HealthTech: What does it mean for compliance? May 2018 Agenda 11:15 AM 11:30 AM Introduction Kathleen Meriwether, Americas Leader - Life Sciences Fraud Investigation & Dispute Services, EY 11:30 AM 12:15
More informationHTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:
HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually
More informationFOREST PRODUCTS: THE SHIFT TO DIGITAL ACCELERATES
FOREST PRODUCTS: THE SHIFT TO DIGITAL ACCELERATES INTRODUCTION While the digital revolution has transformed many industries, its impact on forest products companies has been relatively limited, as the
More informationCOM C. Rozwell
C. Rozwell Research Note 6 October 2003 Commentary Technologies That Ease Pharmaceutical Industry Disruption Several disruptive forces are altering the life science business model. Enterprises must select
More informationPRISME Technical Forum Introduction Accelerating Disruption
PRISME Technical Forum Introduction Accelerating Disruption Presenters: Matthew Rich and Jim Golden Agenda Following the Money: Venture Capital s Influence on Pharma Tech Applications and Possibilities
More informationTechnology and Innovation in the NHS Highlands and Islands Enterprise
Technology and Innovation in the NHS Highlands and Islands Enterprise Introduction Highlands and Islands Enterprise (HIE) welcomes the opportunity to respond to the Committee s call for views. We recognise
More informationMedtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year
www.pwc.com Medtech Slowdown Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year February 2014 2 PwC US venture capital funding for
More informationDecember Eucomed HTA Position Paper UK support from ABHI
December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing
More informationIndustry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Research Note: Key findings
More informationPHARMACEUTICALS: WHEN AI ADOPTION HAS GATHERED MOST MOMENTUM.
PHARMACEUTICALS: WHEN AI ADOPTION HAS GATHERED MOST MOMENTUM www.infosys.com/aimaturity It is critical to make sure that society can take full advantage of the capabilities of AI systems while minimizing
More informationAccenture Technology Vision 2015 Delivering Public Service for the Future Five digital trends: A public service outlook
Accenture Technology Vision 2015 Delivering Public Service for the Future Five digital trends: A public service outlook INFOGRAPHIC Digital government is about using innovative technologies to improve
More informationIsrael Venture Capital Investments Report Q3 2017
Israel Venture Capital Investments Report Q3 2017 NOVEMBER 2017 Summary of Israeli Venture Capital Raising Q3/2017 +14% from Q2/2017 Israeli high-tech capital raising summed up to $1.44B @ ALL RIGHTS RESERVED.
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationSmart devices. How to unlock their potential in the real world. Tobias Handschuh, Ernst & Young
Smart devices How to unlock their potential in the real world Tobias Handschuh, Ernst & Young Smart devices How to unlock their potential in the real world Smart injectors situation today Expectations
More informationTelehealth and Digital Technology. Libbe Englander, PhD
Page 1 of 5 Telehealth and Digital Technology Libbe Englander, PhD Editor s note: This is the first in a series of articles by Dr. Englander that will discuss different elements of the value chain where
More informationAugust 17, The Testimony of Christopher P. Molineaux President & CEO Pennsylvania Bio
Joint Democratic and Republican House Policy Committee Hearing August 17, 2016 The Testimony of Christopher P. Molineaux President & CEO Pennsylvania Bio Chairman Benninghoff, Chairman Sturla, and members
More informationDIGITAL OUTLOOK LIFE SCIENCES INDUSTRY
www.infosys.com INTRODUCTION The life sciences business is facing several challenges as it enters the digital age. Worldwide, sales are slowing down from the heady days of 2014-15 when new drugs for hepatitis
More informationMilitary Robotics - Emerging Trends and Future Outlook. Reference code: DF4580PR Published: July 2015 Single user price: US$1950
Military Robotics - Emerging Trends and Future Outlook Reference code: DF4580PR Published: July 2015 Single user price: US$1950 1 Summary Military Robotics - Emerging Trends and Future Outlook is a report
More informationCHINA MED DEVICE. China Medtech Will Continue Its Double Digit Growth in Years to Come
China Medtech Will Continue Its Double Digit Growth in Years to Come The high level characteristics of medtech in China is focused here. Each of the 6 specific sectors according to SWS recommendation will
More informationEU businesses go digital: Opportunities, outcomes and uptake
Digital Transformation Scoreboard 2018 EU businesses go digital: Opportunities, outcomes and uptake February 2018 Internal Market, Industry, Entrepreneurship and SMEs Executive summary Conditions and outcomes
More informationPharma Session 4: Digital health your health on (the) line
Pharma Session 4: Digital health your health on (the) line Monday, October 16 2017 16:00-17:30 www.aippi.orgg Niklas Mattsson, Awapatent (moderator) Leonore Ryan, formerly of CSIRO and Cardihab Jonathan
More information'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint
'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint STOA workshop - European Parliament, 10 January 2019 Presented
More informationMedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry
More informationTwenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years
Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow The context Demographics On-going financial constraints
More informationFinancing Growth Ventures to Minimize Equity Dilution
Financing Growth Ventures to Minimize Equity Dilution An entrepreneurial team s mission is to develop and grow its venture and to optimize the management team s equity ownership stake. Significant growth
More informationCross-sector convergence in health. An interview with Jacques Mulder
Cross-sector convergence in health An interview with Jacques Mulder Non-traditional entrants are disrupting health. We are already past the point of no return, says EY s Jacques Mulder. Cross-sector convergence
More informationMaking Precision Medicine A Reality: Molecular Diagnostics, Remote Health Status Monitoring and the Big Data Challenge
Making Precision Medicine A Reality: Molecular Diagnostics, Remote Health Status Monitoring and the Big Data Challenge Dr. George Poste Chief Scientist, Complex Adaptive Systems Initiative and Regents
More informationA digital health age how to take on the challenges of this advancing field
Page 1 of 7 Custom Search HOME NEWS OPINION TECHNOLOGY ANALYSIS LATEST ISSU 20 September 2017 11:39 A digital health age how to take on the challenges of this advancing field by Norbert Haberland RSS Print
More informationDigital Health, Technology and Life Sciences. Skip Fleshman
Digital Health, Technology and Life Sciences Skip Fleshman General Partner skip@assetman.com @SkipFleshman, @AMV Firm Facts AMV invests in early stage startups spanning digital health, technology and life
More informationNational Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs
National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs Jeff Shuren Director, CDRH Food and Drug Administration Center for Devices and Radiological Health 1 We face a critical public
More informationCollegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business
More informationEU s Innovative Medical Technology and EMA s Measures
EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency
More informationUSTGlobal. Internet of Medical Things (IoMT) Connecting Healthcare for a Better Tomorrow
USTGlobal Internet of Medical Things (IoMT) Connecting Healthcare for a Better Tomorrow UST Global Inc, August 2017 Table of Contents Introduction 3 What is IoMT or Internet of Medical Things? 3 IoMT New
More informationCompliance for Eucomed: The Medical Technology Industry s s Perspective
Compliance for Eucomed: The Medical Technology Industry s s Perspective Rome, May 29, 2009 John Wilkinson Chief Executive - Eucomed Outline Overview of the Medical Technology Industry What is it? How big
More informationInnovation-Based Economic Development Strategy for Holyoke and the Pioneer Valley
Massachusetts Technology Collaborative John Adams Innovation Institute Innovation-Based Economic Development Strategy for Holyoke and the Pioneer Valley Innovation District Task Force Meeting October 27,
More informationFDA Centers of Excellence in Regulatory and Information Sciences
FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in
More informationDigital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver
Digital Health Jiban Khuntia, PhD Assistant Professor Business School University of Colorado Denver Digital Digital usually refers to something using digits, particularly binary digits. Examples: Digital
More informationData-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
More informationThe Future of Patient Data The Global View Key Insights Berlin 18 April The world s leading open foresight program
The Future of Patient Data The Global View Key Insights Berlin 18 April 2018 The world s leading open foresight program Context Over a 6 month period, 12 expert discussions have taken place around the
More informationTrends in Healthcare Investments and Exits 2018
Trends in Healthcare Investments and Exits 208 208 Massachusetts Life Science Innovation Day Clark Hayes Managing Director Life Science/Healthcare Northeast Head of Business Development SVB Corporate Overview
More informationSmart Living Environments for Active and Healthy Ageing
Smart Living Environments for Active and Healthy Ageing Monika Lanzenberger European Commission - DG CONNECT H.2 @ ETSI Workshop Internet of Things in the Smart Home 22 March 2016 Age-Friendly Housing
More informationThelander 2016 PRIVATE COMPANY YEAR END MERIT INCREASE PITCHBOOK REPORT. J. Thelander Consulting
Thelander 2016 PRIVATE COMPANY YEAR END MERIT INCREASE PITCHBOOK REPORT J. Thelander Consulting 165 Marlin Mill Valley, CA 94941 jt@jthelander.com jthelander.com +1 415.383.7006 Legal Notice: The Thelander
More informationA Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei
A Brief Introduction to the Regulatory Environment of Medical Device Supervision CFDA Department of Legal Affairs Liu Pei Development Trend of Medical Device Industry Development Opportunities of Medical
More informationThe EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki
The EFPIA Perspective on the GDPR Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference 26-27.9.2017, Helsinki 1 Key Benefits of Health Data Improved decision-making Patient self-management CPD
More informationCOMPREHENSIVE COMPETITIVE INTELLIGENCE MONITORING IN REAL TIME
CASE STUDY COMPREHENSIVE COMPETITIVE INTELLIGENCE MONITORING IN REAL TIME Page 1 of 7 INTRODUCTION To remain competitive, Pharmaceutical companies must keep up to date with scientific research relevant
More informatione-care Living Lab - 5 avenue du Grand Sablon La Tronche - FRANCE Tel: +33 (0)
e-care Living Lab e-care Living Lab in Rhône-Alpes Region e-care got the Living Lab label in 2010 from ENoLL e-care Living Lab objectives (1/2) To promote the Living Lab approach in the healthcare sector
More informationMedical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade
Medical Technology Association of NZ Proposed European Union/New Zealand Free Trade Agreement Submission to Ministry of Foreign Affairs & Trade February 2016 1 Introduction The Medical Technology Association
More informationHelping your business grow in the UK health system
Helping your business grow in the UK health system OVERVIEW PROVIDING INSIGHT AND HELPING YOU DELIVER INNOVATIVE PRODUCTS AND SERVICES TO THE NHS AND BEYOND. The health system is a complex and uncertain
More informationLocal Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background
Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded
More informationDiscovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.
Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology
More informationUSTGlobal. How Integrated Data and Technology Affect the Healthcare Ecosystem. UST Global Healthcare Contributed Article
USTGlobal How Integrated Data and Technology Affect the Healthcare Ecosystem UST Global Healthcare Contributed Article UST Global Inc, April 2018 Table of Contents Pharmaceuticals and life sciences Wellness
More informationA Case Study on the Use of Unstructured Data in Healthcare Analytics. Analysis of Images for Diabetic Retinopathy
A Case Study on the Use of Unstructured Data in Healthcare Analytics Analysis of Images for Diabetic Retinopathy A Case Study on the Use of Unstructured Data in Healthcare Analytics: Analysis of Images
More informationGuidelines to Promote National Integrated Circuit Industry Development : Unofficial Translation
Guidelines to Promote National Integrated Circuit Industry Development : Unofficial Translation Ministry of Industry and Information Technology National Development and Reform Commission Ministry of Finance
More informationBringing Technology and Product Development Best Practices Together for Successful Innovation
Bringing Technology and Product Development Best Practices Together for Successful Innovation April 18 19, 2018 * Boston Convention & Exhibition Center Preliminary Agenda AGENDA AT A GLANCE Day One Wednesday,
More informationHealth Care and Digital in Italy. Daniela Bianco, Partner e Responsabile Health Care Unit Alessandro Viviani, Principal Expert Digital Strategy
Health Care and Digital in Italy Daniela Bianco, Partner e Responsabile Health Care Unit Alessandro Viviani, Principal Expert Digital Strategy Key drivers and Health Care evolution 1 2 ECONOMIC RESOURCES
More informationStrategic Alliance Agreement for the Generic Business of Nichi-Iko Pharmaceutical Co., Ltd. and Eisai Co., Ltd.
Strategic Alliance Agreement for the Generic Business of Nichi-Iko Pharmaceutical Co., Ltd. and Eisai Co., Ltd. - Aiming to Create New Business Models and Expand Contribution to Patients - March 29, 2018
More informationApril By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW
Global Transcatheter Aortic Valve Replacement (TAVR) Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region, By Country: Opportunities and Forecast (2017-2022) By Type of Approach-
More informationGlobal Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner
Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis
More informationSeoul Initiative on the 4 th Industrial Revolution
ASEM EMM Seoul, Korea, 21-22 Sep. 2017 Seoul Initiative on the 4 th Industrial Revolution Presented by Korea 1. Background The global economy faces unprecedented changes with the advent of disruptive technologies
More informationTechnology Leadership Course Descriptions
ENG BE 700 A1 Advanced Biomedical Design and Development (two semesters, eight credits) Significant advances in medical technology require a profound understanding of clinical needs, the engineering skills
More informationJURY BOARD BUSINESS/INVESTMENT. Pascal BECACHE Founding President, PBS, Healthcare Industry STRATEGY/BUSINESS
Hosted by : Pascal BECACHE Founding President, PBS, Healthcare Industry INNOLABS IDEAS CONTEST 21 st -22 nd June, Paris JURY BOARD BUSINESS/INVESTMENT Pascal is a seasoned executive with GM and Sales VP
More informationMORE POWER TO THE ENERGY AND UTILITIES BUSINESS, FROM AI.
MORE POWER TO THE ENERGY AND UTILITIES BUSINESS, FROM AI www.infosys.com/aimaturity The current utility business model is under pressure from multiple fronts customers, prices, competitors, regulators,
More informationHow machines learn in healthcare
ADVANCES IN DATA SCIENCE How machines learn in healthcare Machine learning is transforming every facet of healthcare, as computer systems are being taught how to use Big Data to derive insights and support
More informationTransforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value
CADTH 2018 2021 STRATEGIC PLAN Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value Health care costs an estimated $242 billion annually
More informationVenture Capital Search Highlights
Venture Capital Venture funding continued at the strongest pace witnessed over the past decade in 2016, and recruiting the future leaders of the industry s emerging growth companies has never been more
More informationAI use in European healthcare
Artificial Intelligence (AI) AI use in European healthcare www.himss.eu/analytics Results, May 2018 1 TABLE OF CONTENT Introduction & methodology page 3 Survey questions page 4 Results Key Findings page
More informationDigital Health AI in Life Sciences
Digital Health AI in Life Sciences Surging Digital Health AI Fundraising Drives Transformation in Life Sciences DECEMBER Digital Health AI Accelerates Innovation in Life Science Industry Artificial intelligence
More informationIssues in Emerging Health Technologies Bulletin Process
Issues in Emerging Health Technologies Bulletin Process Updated: April 2015 Version 1.0 REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The
More informationExecutive Summary Industry s Responsibility in Promoting Responsible Development and Use:
Executive Summary Artificial Intelligence (AI) is a suite of technologies capable of learning, reasoning, adapting, and performing tasks in ways inspired by the human mind. With access to data and the
More informationReport for the Global South ehealth Observatory THE VIRTUOUS LINK BETWEEN PATIENTS, PHARMACIES AND PHARMACEUTICAL GROUPS.
Report for the Global South ehealth Observatory MCLINICA, THE VIRTUOUS LINK BETWEEN PATIENTS, PHARMACIES AND PHARMACEUTICAL GROUPS Arnaud Auger January 2016, Manila, Philippines Meeting with Farouk Meralli,
More informationFeature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in
Feature Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia Based on our long-term strategic vision toward 2020, our goal is to become #1 in Asia in terms of our
More informationRADIOLOGY August 2017
USA EUROPE CHINA BRAZIL The current challenges faced by a Radiologist Too many patients 38% 45% 47% 53% Long working hours 36% 40% 50% 52% Troubleshooting IT and technical issues 14% 23% 28% 33% Limitations
More informationScience and engineering driving the global economy David Delpy, CEO May 2012
ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL Science and engineering driving the global economy David Delpy, CEO May 2012 A CHANGING LANDSCAPE ROYAL CHARTER - 2003 (replacing Founding Charter of
More informationChina Ophthalmic Hospital Industry Report, May 2013
China Ophthalmic Hospital Industry Report, 2012-2015 May 2013 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationA Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data
External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on
More informationWP6 Genomics Organizing the societal debate on the use of genomic information in healthcare
WP6 Genomics Organizing the societal debate on the use of genomic information in healthcare Wannes Van Hoof, PhD & Chloé Mayeur, MA - Sciensano e-mail: wannes.vanhoof@sciensano.be chloe.mayeur@sciensano.be
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationNational Coordinated Registry Network (CRN) Think-tank
National Coordinated Registry Network (CRN) Think-tank The Value of Real World Data for Innovation within FDA What can CRNs offer? Murray Sheldon, MD Associate Director for Technology and Innovation FDA/CDRH
More informationThe Value of Membership.
The Value of Membership. Driving the global transformation to a smarter, more sustainable world with digital solutions at its core. 2018 gesi.org Information and Communications Technology (ICT) innovators
More informationHealth Innovations in Horizon 2020: the framework programme for research and innovation ( )
Health Innovations in Horizon 2020: the framework programme for research and innovation (2014-2020) Virginija Dambrauskaite, MD, PhD Scientific Officer, Medical Research Unit, Health Directorate Directorate-General
More informationEnabling ICT for. development
Enabling ICT for development Interview with Dr M-H Carolyn Nguyen, who explains why governments need to start thinking seriously about how to leverage ICT for their development goals, and why an appropriate
More informationIntergovernmental Group of Experts on E-Commerce and the Digital Economy First session. 4-6 October 2017 Geneva. Statement by SINGAPORE
Intergovernmental Group of Experts on E-Commerce and the Digital Economy First session 4-6 October 2017 Geneva Statement by SINGAPORE 4 October, Session 1 The views expressed are those of the author and
More informationInnovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
More informationDriving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif
Connect and Catalyse Medicines and Healthcare the Global perspective (+10 years) Zahid Latif % GDP spent on health OECD countries spent nearly $3.5trn in 2005 ($4.6 trillion in 2008) on healthcare services
More informationWHO WE ARE MISSION STATEMENT
WHO WE ARE Parker Life Sciences offers reliable fluidic and motion control products, MetaModules, and systems to customers in life sciences and in analytical instrumentation markets. As part of Parker
More informationImagine your future lab. Designed using Virtual Reality and Computer Simulation
Imagine your future lab Designed using Virtual Reality and Computer Simulation Bio At Roche Healthcare Consulting our talented professionals are committed to optimising patient care. Our diverse range
More informationDigital Transformation in Life Science
Digital Transformation in Life Science Jürgen Peukert, EY partner, Global Life Science Gesundheitskongress des Westens 25. März 2015 1 Gesundheitskongress des Westens 2015 Zukunftsperspektiven im digitalen
More informationParkinson s World A transformational project by The Cure Parkinson s Trust
Parkinson s World A transformational project by The Cure Parkinson s Trust Executive Summary During my time working in the Parkinson s field, I have come to realise there is a patent lack of communication
More informationLeader in Pharmaceutical Films
TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation
More informationMaking London the Heart of the Sport Tech World. A Strategic Plan of Action for Technology in London
Making London the Heart of the Sport Tech World A Strategic Plan of Action for Technology in London Introduction In 2015, London s Blueprint for a Physically Active City was launched, outlining a framework
More informationFRAMEWORK Advances in biomedical technology are
TECHNOLOGY FRAMEWORK Advances in biomedical technology are occurring so rapidly that healthcare professionals can barely keep abreast of the changes. And these advances have cost hospitals dearly. They
More informationINNOVATION : STATE OF PLAY MINING INDUSTRY SURVEY 2017
INNOVATION : STATE OF PLAY MINING INDUSTRY SURVEY 2017 SUMMARY INSIGHTS The 3rd biennial survey of more than 800 global mining leaders reveals the impact of a rapidly changing international marketplace
More informationWhy behavioural economics is essential for the success of the implementation of a wearable or health app. Behavioural Research Unit
Why behavioural economics is essential for the success of the implementation of a wearable or health app Behavioural Research Unit Speakers: Dr Lizzy Lubczanski Research Manager at Swiss Re s Behavioural
More informationBrief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO
Brief to the Senate Standing Committee on Social Affairs, Science and Technology Dr. Eliot A. Phillipson President and CEO June 14, 2010 Table of Contents Role of the Canada Foundation for Innovation (CFI)...1
More informationDaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector
More information